SEOVF (Sernova Biotherapeutics) Ending Cash Position: $0.77 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SEOVF Sernova Biotherapeutics Inc SEOVF
29 GF Score
Price $0.09
! 2 Warning Signs
View Full Analysis

What is Sernova Biotherapeutics Ending Cash Position?

Sernova Biotherapeutics SEOVF +0.01% 29 Ending Cash Position is $0.77 Mil as of Apr. 2026. GuruFocus rates SEOVF with a GF Score™ of 29/100. The stock has 2 warning signs investors should review.

Sernova Biotherapeutics's Ending Cash Position for the quarter that ended in Apr. 2026 was $0.77 Mil.

Sernova Biotherapeutics's quarterly Ending Cash Position increased from Oct. 2025 ($0.19 Mil) to Jan. 2026 ($0.42 Mil) and increased from Jan. 2026 ($0.42 Mil) to Apr. 2026 ($0.77 Mil).

Sernova Biotherapeutics's annual Ending Cash Position declined from Oct. 2023 ($6.36 Mil) to Oct. 2024 ($4.37 Mil) and declined from Oct. 2024 ($4.37 Mil) to Oct. 2025 ($0.19 Mil).

Sernova Biotherapeutics Ending Cash Position Related Terms

Sernova Biotherapeutics Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Sernova Biotherapeutics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sernova Biotherapeutics Ending Cash Position Chart

Sernova Biotherapeutics Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.42 2.76 6.36 4.37 0.19

Sernova Biotherapeutics Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.43 0.06 0.19 0.42 0.77
SEOVF
29GF Score
Sernova Biotherapeutics Inc SEOVF
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sernova Biotherapeutics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Sernova Biotherapeutics's Ending Cash Position for the fiscal year that ended in Oct. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=4.297+-4.108
=0.19

Sernova Biotherapeutics's Ending Cash Position for the quarter that ended in Apr. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.419+0.347
=0.77

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $0.77 Mil mean?
Sernova Biotherapeutics (SEOVF) has a Ending Cash Position of $0.77 Mil as of Apr. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Sernova Biotherapeutics and its competitors.
Is Sernova Biotherapeutics' Ending Cash Position too high?
Sernova Biotherapeutics' current Ending Cash Position is $0.77 Mil. Overall, Sernova Biotherapeutics has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Sernova Biotherapeutics' Ending Cash Position compare to VRTX and REGN?
Sernova Biotherapeutics' Ending Cash Position of $0.77 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Sernova Biotherapeutics and its competitors. Sernova Biotherapeutics's current Ending Cash Position is $0.77 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sernova Biotherapeutics stock overvalued right now?
Sernova Biotherapeutics (SEOVF) has a current Ending Cash Position of $0.77 Mil. The current Ending Cash Position is $0.77 Mil. Sernova Biotherapeutics' overall GF Score™ is 29/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Sernova Biotherapeutics (SEOVF), the current Ending Cash Position is $0.77 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sernova Biotherapeutics Business Description

Other Exchanges PSH0:GermanySVA:Canada
Address RPO Central Parkway, PO Box 29592, Mississauga, ON, CAN, L5A 4H2
Sernova Biotherapeutics Inc is a clinical-stage biotechnology company focused on advancing regenerative medicine for the treatment of chronic diseases. The Company's primary asset is its proprietary Cell Pouch, a bio-hybrid organ system designed to enhance the delivery of cell therapy by replicating natural body functions. The Cell Pouch creates a vascularized, organ-like environment that promotes the longevity and functionality of therapeutic cells and ensures containment for retrievability.
29GF Score

Get the complete analysis for SEOVF

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.09
Price